Endpoint Health

Endpoint Health

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://www.endpointhealth.com

Last Round

Series A

Jun 2, 2022

Est. Valuation

$2.14M

Total Funding Raised

$52.15M

Company Overview

Endpoint Health is a biotechnology company focused on delivering precision therapies and improving outcomes for patients with immune-driven illnesses through the development and commercialization of personalized therapeutics and therapy-guiding tests.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Application

Keywords

precision medicinecompanion diagnosticsAI drug discoverytheranosticssepsis treatmentARDS treatmentacute respiratory distress syndromepatient stratificationcritical illness therapeuticsbiomarker discoverydrug development platformimmunologymedical AIclinical-stage biopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Endpoint Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Endpoint Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AJun 2, 2022
VC RoundJul 13, 2020
AcceleratorJan 1, 2019

Key People

Founding team and executive leadership

Leonardo Maestri Teixeira

Co-Founder COO

Founding Team

Jason Springs

Co-Founder And CEO

Founding Team

Endpoint Health Investors

Notable investors and investment history

InvestorRounds
Boom Capital VenturesSeries A
YAYA CapitalSeries A
Wireframe VenturesSeries A, VC Round
Boom CapitalSeries A
Alix VenturesSeries A
HCX VenturesSeries A
Humboldt FundSeries A

Endpoint Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Endpoint Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Endpoint Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range7
Year Founded2018
Last FundingJun 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.